PRO-IMPLANT is sponsor of a prospective interventional clinical trial, evaluating the role of intravenous fosfomycin in the treatment of PJI, holding the acronym “PROOF-Study” (Prosthetic Joint Infection Outcome with Fosfomycin). In this study, the outcome of a fosfomycin-containing antibiotic regimen is investigated. Currently, 8 of 25 study centers in Germany are already recruiting patients in this study.
Of planned 226 patients, 76 have already been already included in 8 hospitals: Berlin, Dresden, Düsseldorf, Köln, Weimar, Hildesheim, Regensburg, Bochum. The following study centers will start soon: Bonn, Mainz, Eisenberg, Essen, Wuppertal, Münster, Wriezen, Minden.
The PROOF Study Synopsis (Treatment Algorithm) and the issued Newsletters are available here: